Class III

Drug Recall: Mercaptopurine Tablets, USP 50 mg, packaged in: a) 25-count bottle (NDC 69076-913-02), b) 250-count bottle (NDC 69076-913-25), Rx only, Manufactured for: Quinn Pharmaceuticals, Boca Raton, FL, www.qui

Stason Pharmaceuticals, Inc. · February 9, 2024

Reason for Recall

Failed Dissolution Specifications: results slightly under spec at at 9-months.

Product Description

Mercaptopurine Tablets, USP 50 mg, packaged in: a) 25-count bottle (NDC 69076-913-02), b) 250-count bottle (NDC 69076-913-25), Rx only, Manufactured for: Quinn Pharmaceuticals, Boca Raton, FL, www.quinnrx.com

Distribution

USA Nationwide

States Affected

NATIONWIDE

Quantity Affected

54, 131 bottles

Source: FDA (openFDA Drug Enforcement)

Recall number: D-0367-2024

Status: terminated

SafeCheck provides drug interaction information from FDA-approved product labeling (openFDA). This is for informational purposes only and is not medical advice. Always consult your healthcare provider before making medication decisions.